By Peter Yim | TrialSite News | April 1, 2021 WHO updated “Therapeutics and COVID-19” on March 31, 2021 to include a recommendation on ivermectin. The recommendation was: “We recommend not to use ivermectin in patients with COVID-19 except in the context of a clinical trial.” The recommendation was made by the Guideline Development Group; […]
Source